198 related articles for article (PubMed ID: 11914031)
1. Somatic mutations in thyroid nodular disease.
Krohn K; Paschke R
Mol Genet Metab; 2002 Mar; 75(3):202-8. PubMed ID: 11914031
[TBL] [Abstract][Full Text] [Related]
2. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations.
Krohn K; Wohlgemuth S; Gerber H; Paschke R
J Pathol; 2000 Sep; 192(1):37-42. PubMed ID: 10951398
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.
Derwahl M; Manole D; Sobke A; Broecker M
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S6-9. PubMed ID: 9867188
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.
Sancak S; Jaeschke H; Eren F; Tarcin O; Guellueoglu B; Sen LS; Sever Z; Gozu HI; Bircan R; Akalin S; Paschke R; Eszlinger M
Horm Metab Res; 2011 Jul; 43(8):562-8. PubMed ID: 21773967
[TBL] [Abstract][Full Text] [Related]
5. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
Paschke R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
[TBL] [Abstract][Full Text] [Related]
6. The detection of somatic mutations of thyrotropin receptor gene in fine needle biopsy samples from thyroid nodules.
Syrenicz A; Kurzawski G; Ciechanowicz A
Endocr Regul; 1999 Sep; 33(3):95-101. PubMed ID: 10571960
[TBL] [Abstract][Full Text] [Related]
7. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
8. [Molecular aspects in the pathogenesis of nodules and adenomas of the thyroid gland].
Derwahl M
Schweiz Med Wochenschr; 1994 Sep; 124(37):1613-8. PubMed ID: 7939528
[TBL] [Abstract][Full Text] [Related]
9. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey.
Gozu HI; Bircan R; Krohn K; Müller S; Vural S; Gezen C; Sargin H; Yavuzer D; Sargin M; Cirakoglu B; Paschke R
Eur J Endocrinol; 2006 Oct; 155(4):535-45. PubMed ID: 16990652
[TBL] [Abstract][Full Text] [Related]
10. Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas.
Derwahl M
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():32-5. PubMed ID: 8980997
[TBL] [Abstract][Full Text] [Related]
11. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations.
Krohn K; Führer D; Holzapfel HP; Paschke R
J Clin Endocrinol Metab; 1998 Jan; 83(1):130-4. PubMed ID: 9435429
[TBL] [Abstract][Full Text] [Related]
12. Ras mutations are rare in solitary cold and toxic thyroid nodules.
Krohn K; Reske A; Ackermann F; Müller A; Paschke R
Clin Endocrinol (Oxf); 2001 Aug; 55(2):241-8. PubMed ID: 11531932
[TBL] [Abstract][Full Text] [Related]
13. Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway.
Georgopoulos NA; Sykiotis GP; Sgourou A; Papachatzopoulou A; Markou KB; Kyriazopoulou V; Papavassiliou AG; Vagenakis AG
Eur J Endocrinol; 2003 Oct; 149(4):287-92. PubMed ID: 14514342
[TBL] [Abstract][Full Text] [Related]
14. [Point mutations of the thyrotropin receptor gene in autonomously functioning thyroid gland nodules: correlation with clinical findings and morphology].
Lax SF; Semlitsch G; Schauer S; Zatloukal K; Langsteger W; Eber O; Höfler G
Verh Dtsch Ges Pathol; 1997; 81():145-50. PubMed ID: 9474865
[TBL] [Abstract][Full Text] [Related]
15. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].
Derwahl M
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046
[TBL] [Abstract][Full Text] [Related]
16. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356
[TBL] [Abstract][Full Text] [Related]
17. Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules.
Eszlinger M; Jaeschke H; Paschke R
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):393-7. PubMed ID: 17940470
[TBL] [Abstract][Full Text] [Related]
18. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
Kosugi S
Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
[TBL] [Abstract][Full Text] [Related]
19. Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis.
Tonacchera M; Vitti P; De Servi M; Agretti P; De Marco G; Chiovato L; Pinchera A
J Endocrinol Invest; 2003; 26(2 Suppl):2-6. PubMed ID: 12762632
[TBL] [Abstract][Full Text] [Related]
20. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis.
Trülzsch B; Krohn K; Wonerow P; Chey S; Holzapfel HP; Ackermann F; Führer D; Paschke R
J Mol Med (Berl); 2001; 78(12):684-91. PubMed ID: 11434721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
